IMAC Holdings, Inc. (IMAC): Price and Financial Metrics


IMAC Holdings, Inc. (IMAC): $1.56

0.07 (+4.70%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IMAC POWR Grades


  • Sentiment is the dimension where IMAC ranks best; there it ranks ahead of 90.09% of US stocks.
  • IMAC's strongest trending metric is Stability; it's been moving up over the last 206 days.
  • IMAC ranks lowest in Quality; there it ranks in the 1st percentile.

IMAC Stock Summary

  • IMAC Holdings Inc's market capitalization of $19,753,587 is ahead of just 5% of US-listed equities.
  • IMAC's went public 2.25 years ago, making it older than only 5.21% of listed US stocks we're tracking.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for IMAC comes in at -44.62% -- higher than that of only 6.13% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to IMAC Holdings Inc, a group of peers worth examining would be CEMI, WRLD, SANW, TELA, and ATRO.
  • Visit IMAC's SEC page to see the company's official filings. To visit the company's web site, go to www.imacregeneration.com.

IMAC Price Target

For more insight on analysts targets of IMAC, see our IMAC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $3.68 Average Broker Recommendation 1.67 (Moderate Buy)

IMAC Stock Price Chart Interactive Chart >

Price chart for IMAC

IMAC Price/Volume Stats

Current price $1.56 52-week high $2.73
Prev. close $1.49 52-week low $0.64
Day low $1.48 Volume 119,900
Day high $1.61 Avg. volume 471,218
50-day MA $1.79 Dividend yield N/A
200-day MA $1.40 Market Cap 20.88M

IMAC Holdings, Inc. (IMAC) Company Bio


IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Brentwood, TN.


IMAC Latest News Stream


Event/Time News Detail
Loading, please wait...

IMAC Latest Social Stream


Loading social stream, please wait...

View Full IMAC Social Stream

Latest IMAC News From Around the Web

Below are the latest news stories about IMAC Holdings Inc that investors may wish to consider to help them evaluate IMAC as an investment opportunity.

IMAC Holdings Reports First Quarter 2021 Financial Results and Corporate Update

BRENTWOOD, Tenn., May 13, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced financial results for the first quarter ended March 31, 2021. Financial Highlights from 1Q 2021 (all comparisons are for the quarter ended March 31, 2020, unless otherwise indicated): Cash as of March 31, 2021 was $15.6 million compared to $2.6 million as of December 31, 2020Total revenue was $3.1 million, compared with $3.3 million, a decline of 8%Net loss was $2.0 million or $0.15 per share, compared with a net loss of approximately $1.7 million or $0.18 per share Corporate Highlights in Q1 2021 and Y...

Yahoo | May 13, 2021

IMAC Holdings to Participate at the Benzinga Global Small Cap Conference and Present to Investors on May 13, 2021

Brentwood, Tenn., May 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announced today that management will participate at the Benzinga Global Small Cap Conference on May 13, 2021. Chief Executive Officer Jeffrey Ervin will deliver his corporate presentation at 3:30pm ET on May 13, 2021. Investors can also request a one-on-one meeting with Mr. Ervin to be arranged following the conclusion of the conference. Investors can register for the conference here: https://www.benzinga.com/events/small-cap/global/ About IMAC Holdings, Inc. IMAC was created in March 2015 to expand on the footprint of the original I...

Yahoo | May 7, 2021

Will IMAC Holdings, Inc. (IMAC) Report Negative Q1 Earnings? What You Should Know

IMAC Holdings, Inc. (IMAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | May 6, 2021

IMAC Holdings CEO Jeff Ervin Provides Corporate Update in Letter to Shareholders

Brentwood, Tenn., April 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitative orthopedic treatments without the use of surgery or opioids, today issued a corporate update in a Letter to Shareholders from CEO Jeff Ervin. To Our Valued Shareholders: I am excited about the progress we made since completing our equity offering one month ago. While there hasn’t been a singular event to trigger material disclosures, IMAC has been productive with each of our business lines and is pleased to provide interim updates on some of our growth initiatives. The Back Space, our new retail spine and neck care venture, now has a foundational platform for the business to grow into a nati...

Yahoo | April 26, 2021

IMAC Holdings Announces Closing of its Public Offering of Common Stock for Total Gross Proceeds of $17.0 Million

Brentwood, Tenn., March 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (the “Company” or “IMAC”) (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, today closed its previously announced underwritten public offering of 10,625,000 shares of common stock at a public offering price of $1.60 per share, for total gross proceeds of $17.0 million. The net proceeds, after underwriting discounts, but before estimated expenses of the offering payable by IMAC, were approximately $16.0 million. All shares of common stock sold in the offering were sold by the Company, except that the Company, together with its co-founder and chief operating officer as a selling sto...

Yahoo | March 26, 2021

Read More 'IMAC' Stories Here

IMAC Price Returns

1-mo -7.14%
3-mo -37.60%
6-mo 51.46%
1-year -6.02%
3-year N/A
5-year N/A
YTD 1.96%
2020 2.00%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.856 seconds.